Re: here is what I think
But the optimist in me could still be convinced I am wrong-this board however other than fmrick( who did offer his thoughts) offers little in the way of fodder for debate- I still, given the small company size don't understand the approval to file issue- in the biogen example it seems to me that a fda approved trial once completed should go from trial completion to approval to file in a matter of months and then filing 6 more months but the willingness of the fda to accept the NDA just is not meant to be a full analysis of whether it is ultimately approved or not. So I still wonder what is the difference here. I am not sure why this question has not been asked and answered over and over in every CC during this last year.